In this study cohort, we experienced one patient with COVID-19 due to Omicron variant who presented prolonged IL-6 elevation with deteriorated pulmonary lesions and subsequently required > 2 months of corticosteroid administration. This evidence concerns the gene IL6 and COVID-19.